• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON ASPHERIC UV ABSORBING IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON ASPHERIC UV ABSORBING IOL; INTRAOCULAR LENS Back to Search Results
Model Number CC60WF
Device Problem Defective Device (2588)
Patient Problems Eye Injury (1845); Headache (1880); Blurred Vision (2137); Visual Disturbances (2140); Excessive Tear Production (2235); Eye Pain (4467); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
The product was not returned for analysis; the lens remains implanted.Complaint history and product history records were reviewed, and documentation indicated the product met release criteria.Root cause has not been identified.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event Description
A non-healthcare professional reported that following a cataract extraction with intraocular lens (iol) implant procedure, the implanted lens was defective and caused trauma in the eye.The eye was swollen and unable to open for 4 days.The eye kept watering nonstop and also pain in eye area and headache for 6 days and lost time at work and eye stilled did not open up fully until week 3.The eye is now sensitive to bright light and requires sunglasses at work and around the house, blur vision.Additional information was requested and received from the initial reporter, who stated that this event has affected me, my daily life, and my work in several ways.The left eye still has not healed 100 percent, and i still do not have a prescription for corrected eye glasses because it has not healed.
 
Manufacturer Narrative
The product was not returned.Product history records were reviewed and documentation indicated the product met release criteria.Qualified associated products were indicated.The product investigation could not identify a root cause for the reported complaint.The product was not returned.The lens remains implanted.The reporter was the patient.The implanting facility provided the following information.When the initial iol was inserted in the patient's eye it appeared the back haptic was damaged, the iol was removed and this iol was placed without incident.Information was provided that the first day post op for the left eye the patient had not been using their eye drops as instructed.The patient's vision at the 1-day post-op, (b)(6), was 20/300 with inflammation present.On (b)(6), the patient's vision was 20/150 with improvement of the inflammation.Was there patient harm-no.The patient's vision before surgery was 20/300, last post-op visit it was 20/80 pinhole.The surgeon's prognosis is that the patient will continue to improve.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Additional information provided in b.5.The manufacturer internal reference number is: (b)(6).
 
Event Description
Additional information was requested and received from the initial reporter who stated that left eye was still having issues of cloudiness.There was a haze on the left eye toward the left side of the eye.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON ASPHERIC UV ABSORBING IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key16494145
MDR Text Key310777149
Report Number1119421-2023-00400
Device Sequence Number1
Product Code HQL
UDI-Device Identifier00380652396714
UDI-Public00380652396714
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P190018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 07/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCC60WF
Device Lot Number15458870
Was Device Available for Evaluation? No
Date Manufacturer Received06/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/03/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CLAREON MONARCH IV INJECTOR.; MONARCH III CARTRIDGE D.; PROVISC.
Patient Outcome(s) Other;
Patient Age53 YR
Patient SexFemale
-
-